STOCK TITAN

Zura Bio (NASDAQ: ZURA) director plans 50,000-share sale after prior trades

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Zura Bio Ltd (ZURA) received a notice under Rule 144 that director Someit Sidhu intends to sell common shares. The planned transaction involves 50,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate value of $287,712.50, currently associated with NASDAQ trading on 08/18/2026. The shares are tied to a stock option exercise for cash from the issuer on the same date. Over the prior three months, the same person reported additional sales of ZURA common stock.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 50,000 shares Common stock intended for sale under Rule 144
Aggregate value of planned sale $287,712.50 Total for 50,000 common shares listed with broker
Planned sale date 08/18/2026 Date associated with the 50,000-share transaction
Shares sold 08/17/2026 27,000 shares Common shares sold by Someit Sidhu during past three months
Proceeds 08/17/2026 $151,343.10 Aggregate proceeds from 27,000-share sale
Shares sold 08/14/2026 40,000 shares Common shares sold by Someit Sidhu during past three months
Shares sold 08/13/2026 51,000 shares Common shares sold by Someit Sidhu during past three months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"Common | 08/18/2026 | Stock Option Exercise | Issuer |"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate value financial
"Common ... | 50000 | 287712.50 |"

FAQ

What insider sale is disclosed for ZURA in this Form 144?

The notice reports that Someit Sidhu, a director of Zura Bio Ltd, intends to sell 50,000 common shares. The planned sale has an aggregate value of $287,712.50 and is associated with a stock option exercise dated 08/18/2026.

How many ZURA shares has Someit Sidhu sold recently under Rule 144?

The filing lists prior sales of 27,000 shares on 08/17/2026, 40,000 shares on 08/14/2026, and 51,000 shares on 08/13/2026. Aggregate proceeds were $151,343.10, $220,540.00, and $287,043.30, respectively.

Which broker is handling the planned ZURA share sale?

The planned sale of 50,000 Zura Bio Ltd common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the transaction.

What is the nature of the ZURA shares to be sold on 08/18/2026?

The 50,000 Zura Bio Ltd common shares are indicated as arising from a Stock Option Exercise with the issuer, for cash, dated 08/18/2026. The Form 144 identifies these as the securities intended for sale.

Who is the person selling ZURA shares under this Form 144?

The person is Someit Sidhu, identified as a director of Zura Bio Ltd. The notice states that the securities are being sold for this person’s account, as defined under paragraph (a) of Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature